MILBEMAX BROAD-SPECTRUM ALLWORMER TABLETS FOR CATS OVER 2 KG BODYWEIGHT

Country: Australia

Language: English

Source: APVMA (Australian Pesticides and Veterinary Medicines Authority)

Buy It Now

Active ingredient:

MILBEMYCIN OXIME; PRAZIQUANTEL

Available from:

ELANCO AUSTRALASIA PTY LTD

INN (International Name):

milbemycin oxime(16mg/Tb)+praziquantel(40mg/Tb)

Pharmaceutical form:

ORAL TABLET

Composition:

MILBEMYCIN OXIME ANTIBIOTIC Active 16.0 mg/Tb; PRAZIQUANTEL ANTHELMINTIC Active 40.0 mg/Tb

Units in package:

2tablets

Class:

VM - Veterinary Medicine

Manufactured by:

ELANCO AUSTRALASIA

Therapeutic group:

CAT - OVER 2 KG

Therapeutic area:

PARASITICIDES

Therapeutic indications:

HEARTWORM - PREVENTION OF | HOOKWORM - ANCYLOSTOMA TUBAEFORME | ROUNDWORM - TOXASCARIS LEONINA | ROUNDWORM - TOXOCARA CATI | TAPEWORM - DIPYLIDIUM CANINUM | TAPEWORM - TAENIA SPP. | ASCARID | HUMAN INTESTINAL ROUNDWORM | TO PREVENT HEARTWORM | TOXOCARA MYSTAX

Product summary:

Poison schedule: 5; Withholding period: WHP: N/A; Host/pest details: CAT - OVER 2 KG: [HEARTWORM - PREVENTION OF, HOOKWORM - ANCYLOSTOMA TUBAEFORME, ROUNDWORM - TOXASCARIS LEONINA, ROUNDWORM - TOXOCARA CATI, TAPEWORM - DIPYLIDIUM CANINUM, TAPEWORM - TAENIA SPP.]; For the treatment and control of adult and immature roundworm, adult and immature hookworm and tapeworm infections in cats over 2kg bodyweight. For the prevention of heartworm in cats over 2kg bodyweight when administered monthly.For oral treatment of cats only.

Authorization status:

Registered

Authorization date:

2023-07-01

Patient Information leaflet

                                MILBEMAX BROAD-SPECTRUM ALLWORMER TABLETS FOR CATS OVER 2 KG
BODYWEIGHT
63970/125981
Product Name:
APVMA Approval No:
Label Name:
MILBEMAX BROAD-SPECTRUM ALLWORMER TABLETS FOR CATS OVER 2 KG
BODYWEIGHT
Signal Headings:
CAUTION
KEEP OUT OF REACH OF CHILDREN
FOR ANIMAL TREATMENT ONLY
Constituent
Statements:
16 mg/Tb MILBEMYCIN OXIME
40 mg/Tb PRAZIQUANTEL
Claims:
Treat and control gastrointestinal worms:
• Adult and immature roundworm (Toxocara cati, Toxascaris leonina)
• Adult and immature hookworm (Ancylostoma tubaeforme)
• Tapeworm (Dipylidium caninum, Taenia spp.)
And, if given monthly:
• Prevent heartworm (Dirofilaria immitis).
Beef flavoured tablets
Net Contents:
2tablets
Directions for Use:
Restraints:
Contraindications:
Precautions:
Side Effects: RLP APPROVED
Dosage and
Administration:
IMPORTANT
The safety of MILBEMAX in heartworm positive cats has not been
established. An
examination for existing heartworm infection prior to commencement of
treatment is
recommended.
Consult a veterinarian.
MILBEMAX Tablets should be given by mouth. The minimum dose is 2 mg
milbemycin
oxime and 5 mg praziquantel per kg bodyweight.
INTRODUCTION
Controlling roundworm, hookworm, tapeworm and preventing heartworm
infections is
essential for the good health of cats.
INDICATIONS
For control of gastrointestinal worms:
MILBEMAX Broad-Spectrum Allwormer Tablets for Small Cats 0.5 – 2 kg
bodyweight
should be administered orally to kittens at 6, 8 and 12 weeks of age,
then every 3 months.
MILBEMAX Broad-Spectrum Allwormer Tablets for Cats over 2 kg
bodyweight should be
administered to cats weighing over 2 kg. Pregnant queens should be
treated at mating
and before birth of kittens. Nursing queens should be treated at the
same time as their
kittens. Adult cats should be treated every 3 months. If worm problems
persist, consult a
veterinarian.
For heartworm prevention:
MILBEMAX Tablets must be administered orally every month, preferably
on the same
date each month. If you miss the monthly interval, administer MILBEMAX
immediatel
                                
                                Read the complete document
                                
                            

Summary of Product characteristics

                                 
  PRODUCT NAME: MILBEMAX
®
 TABLETS FOR CATS 
                                         
              PAGE NO:             1 OF 4 
                                         
              DATE OF ISSUE:     NOVEMBER 2008 
 
                                          
MATERIAL SAFETY DATA SHEET 
Novartis Animal Health Australasia Pty Ltd 
 
SECTION 1 - IDENTIFICATION OF CHEMICAL PRODUCT AND COMPANY 
COMPANY DETAILS: 
NOVARTIS ANIMAL HEALTH AUSTRALASIA PTY LIMITED 
PHONE: (02)  9805 3555 
A.C.N. 076 745 198  
FAX:      (02)  9888 8387 
54 WATERLOO ROAD 
 
NORTH RYDE NSW 2113 
 
 
PRODUCT NAME:               
MILBEMAX
®
 Tablets for Cats 
ACTIVE INGREDIENTS:  
 
Milbemycin oxime and Praziquantel 
CIBA-GEIGY CODE :                
Milbemycin oxime (CGA 179246); Praziquantel (CGA 184699) 
PRODUCT USE:  
 
For the treatment and control of adult and immature roundworm 
(_Toxocara cati, Toxascaris leonina_) for the treatment and
control of 
adult and immature hookworm (_Ancylostoma tubaeforme_) the
treatment 
and control of tapeworm infections (_Dipylidium caninum,
Taenia spp_.) 
and the prevention of heartworm (_Dirofilaria immitis_) in cats over
2 kg 
bodyweight. 
REVISION DATE:     
    
November 2008 
SECTION 2    HAZARDS IDENTIFICATION 
HAZARD CLASSIFICATION:        
Hazardous Substance 
Non-Dangerous Goods 
RISK PHRASES:                      
R20/22 Harmful by inhalation and if swallowed.  
R50/53 Very toxic to aquatic organisms may cause
long-term adverse 
effects in the aquatic environment. 
SAFETY PHRASES:                   
None 
SUSDP CLASSIFICATION:       
5 
UN NUMBER:                       
None Allocated 
SECTION 3   COMPOSITION / INFORMATION ON INGREDIENTS 
INGREDIENTS 
CAS NO. 
CONTENT 
(MG/TABLET) 
Milbemycin oxime 
[1294-96-2]

                                
                                Read the complete document